Stem Cell Study Reveals Universal Checkpoint Controlling Cell Identity

Researchers from the University of Southern California (USC) and the National Institute of Environmental Health Sciences (NIEHS) have identified the protein GSK3α as a universal stemness checkpoint that controls the identity of various stem cell types across different developmental stages. The findings, published in Cell Research and announced on April 9, 2026, suggest that inhibiting this protein can maintain stem cell identity by blocking the signals that drive differentiation into specialized cells.

The discovery introduces a new conceptual framework for stem cell biology. Rather than viewing the maintenance of stem cells as the result of numerous unrelated signaling conditions, the research indicates that distinct stem cell types share common checkpoints to preserve their state.

The Role of GSK3α in Stem Cell Identity

For nearly two decades, the scientific community has operated under the understanding that stem cell self-renewal depends on the ability to block differentiation signals. This concept was previously explored in a 2008 Nature paper titled The ground state of embryonic stem cell self-renewal by Austin Smith and Qi-Long Ying.

The latest research identifies GSK3α as a specific checkpoint that drives the process of differentiation. By inhibiting this protein, scientists can maintain the identity of stem cells, preventing them from transitioning into more specialized cell types.

We already knew that blocking differentiation is essential for maintaining stem cells. What this study shows is that Notice specific checkpoints controlling this process, and that these checkpoints are shared across different stem cell states.

Qi-Long Ying, professor of stem cell biology and regenerative medicine at the Keck School of Medicine of USC

Comparative Analysis of Pluripotent Stem Cells

To investigate whether different pluripotent stem cells (PSCs) share intrinsic mechanisms for self-renewal, the research team compared mouse embryonic stem cells (mESCs) and mouse epiblast-derived stem cells (mEpiSCs). These two cell types possess distinct developmental identities and typically rely on opposing signaling pathways for self-renewal.

mESCs are derived from the inner cell mass and maintain self-renewal under the 2i condition, which activates WNT signaling and inhibits FGF/MEK signaling. In contrast, mEpiSCs are post-implantation cells that require a combination of activin A, bFGF, and XAV939, known as AFX conditions.

While mESCs can transition into an mEpiSC-like state under AFX conditions, the reverse transition rarely occurs. This difference highlights the distinct regulatory logic underlying the pluripotency of these two cell types.

Small-Molecule Screening and Validation

The researchers performed a small-molecule screen using a focused library of 164 compounds targeting pathways related to stemness and cell proliferation. The goal was to identify factors capable of sustaining both mESCs and mEpiSCs despite their differing regulatory needs.

The screen identified several candidates that enhanced mESC colony formation. Five top-ranking compounds were selected for further validation:

• BRD0705
• Acetylcysteine
• TG100-115
• Doramapimod
• IWR1

The study utilized GSK3α inhibition to co-culture mouse embryonic stem cells and mouse epiblast stem cells, during which both cell types maintained their distinct identities.